Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Crispr Therapeutics AG (1CG) vs. Competitors

22 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:1CGCrispr Therapeutics AGEUR 38.00EUR 3.55B-8.48-19.83%Moderate BuyUnlock the DE:1CG analyst price target with TipRanks PremiumDE:1CGUnlock the DE:1CG top-analyst price target with TipRanks Premium
NTLAIntellia Therapeutics$9.77$1.37B-2.9215.35%HoldUnlock the NTLA analyst price target with TipRanks PremiumDE:1CG vs NTLAUnlock the NTLA top-analyst price target with TipRanks Premium
BEAMBeam Therapeutics$21.01$2.17B-21.01-4.15%Strong BuyUnlock the BEAM analyst price target with TipRanks PremiumDE:1CG vs BEAMUnlock the BEAM top-analyst price target with TipRanks Premium
LEGNLegend Biotech$16.25$3.15B-1625.00-44.77%Moderate BuyUnlock the LEGN analyst price target with TipRanks PremiumDE:1CG vs LEGNUnlock the LEGN top-analyst price target with TipRanks Premium
KYMRKymera Therapeutics$121.13$10.37B-33.3788.35%Strong BuyUnlock the KYMR analyst price target with TipRanks PremiumDE:1CG vs KYMRUnlock the KYMR top-analyst price target with TipRanks Premium

Performance Comparison

-50%0%50%100%150%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:1CGCrispr Therapeutics AG38.00-7.60-16.67%
NTLAIntellia Therapeutics9.771.5318.57%
BEAMBeam Therapeutics21.010.030.14%
LEGNLegend Biotech16.25-11.75-41.96%
KYMRKymera Therapeutics121.1356.3186.87%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts